We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Ultrahigh Field MRI Technology Provides More Effective Diagnosis of Breast Cancer

By HospiMedica International staff writers
Posted on 19 Mar 2014
Austrian scientists have demonstrated for the first time that a 7-Tesla ultrahigh-field magnetic resonance imaging (MRI) can be used for clinical applications in patients with breast tumors. More...
This may in help, in the near future, to provide a more effective breast cancer diagnosis.

The scientists’ study was published in the April 2014 issue of the journal European Radiology. In earlier research involving 7-Tesla MRI, the clinical application of the technology had been restricted to only one breast due to the limited coil technology available. “The new generation of coils allows clinical application on both sides,” explained Dr. Katja Pinker from the MedUni Vienna department of radiology and nuclear medicine, department of molecular imaging at the Medical University of Vienna (MedUni; Vienna; Austria), where the study was performed in collaboration with the High Field MR Center of Excellence and the Breast Health Center at the MedUni Vienna and Vienna General Hospital.

The 7-Tesla MRI scanner has a high diagnostic accuracy of 96.6%. Dr. Pinker stated, “The higher signal available with 7T [7 Tesla] permits a higher resolution, allowing fine details to be visualized better and a more certain diagnosis to be made. Diagnosis at molecular and metabolic level is also possible with diffusion-weighted or sodium imaging and spectroscopy, helping us to characterize tumors even more effectively.”

The overall outcome of the findings was that bilateral ultrahigh-field MRI of the breast with 7-Tesla can be used clinically without difficulties and “allows patients with breast tumors to be diagnosed more accurately,” the Dr. Pinker. “The future enhancement of ultrahigh-field MRI of the breast with 7-Tesla using molecular and metabolic imaging could represent a further step towards personalized medicine, since not every type of breast cancer is the same.”

By way of comparison, the current clinical standard MRI scans using a 3-Tesla device produce a diagnostic accuracy of up to 93% with the best equipment. The scanning time is also the same, whether it is a 3-Tesla or 7-Tesla MR scanner. The patient spends just over 15 minutes in the tunnel.

The clinical use of 7-Tesla in the examination of breast tumors is therefore possible immediately; however, it also depends on the availability of suitable equipment. Worldwide, there are only eight university institutions that have a 7-Tesla device, including one at the MedUni Vienna/Vienna General Hospital. The 7-Tesla MRI scanner has been around for five years at the MedUni Vienna, and it is the only device of its kind in Austria. The Center of Excellence for High Field MR is one of the world’s leading facilities for this technology.

Related Links:

Medical University of Vienna



Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Immobilization System
Cranial 4Pi Immobilization
Tourniquet System
heidi– mein Tourniquet
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Sphere-9 is the first all-in-one mapping and ablation, large-tip focal, dual-energy catheter to be CE marked for ventricular ablation (Photo courtesy of Medtronic)

Dual-Energy Mapping and Ablation Catheter Receives CE Mark for Ventricular Arrhythmias

Ventricular arrhythmias, including ventricular tachycardia and premature ventricular complexes, can be life-threatening and often occur in patients with advanced heart disease. Although catheter ablation... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.